Singapore - English - HSA (Health Sciences Authority)

medicare (s) pte ltd - radiology / imaging - it is intended for use in gynecology, obstetrics, small parts, vascular, musculoskeletal, orthopedics, pediatric hip, cardiac, adult cardiac, pediatric cardiac, neonatal cardiac, abdomen, adult abdomen, pediatric abdomen, neonatal abdomen, transcranial, adult transcranial, neonatal cephalic exams.

Singapore - English - HSA (Health Sciences Authority)

medicare (s) pte ltd - radiology / imaging - the dc-8 exp diagnostic ultrasound system is applicable for obstetrics, gynecology, adult abdomen, pediatric abdomen, vascular, nerve, urology, musculoskeletal, small parts, pediatric hip, neonatal cephalic, adult cardiac, pediatric cardiac and adult transcranial exams.

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة ألفه للأدوية - ulfa pharma co. - diltiazem hcl 60 mg - 60 mg

Israel - English - Ministry of Health

novartis israel ltd - methylphenidate hydrochloride - tablets - methylphenidate hydrochloride 10 mg - methylphenidate - methylphenidate - attention deficit hyperactivity disorder (adhd). narcolepsy.

United States - English - NLM (National Library of Medicine)

lupin pharmaceuticals, inc. - imipramine hydrochloride (unii: bke5q1j60u) (imipramine - unii:ogg85sx4e4) - imipramine hydrochloride 10 mg - for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than other depressive states. one to three weeks of treatment may be needed before optimal therapeutic effects are evident. may be useful as temporary adjunctive therapy in reducing enuresis in children aged 6 years and older, after possible organic causes have been excluded by appropriate tests. in patients having daytime symptoms of frequency and urgency, examination should include voiding cystourethrography and cystoscopy, as necessary. the effectiveness of treatment may decrease with continued drug administration. the concomitant use of monoamine oxidase inhibiting compounds is contraindicated. hyperpyretic crises or severe convulsive seizures may occur in patients receiving such combinations. the potentiation of adverse effects can be serious, or even fatal. when it is desired to substitute imipramine hydrochloride tablets in patients receiving a monoamine oxidase inhibitor, as long an interval should elapse as the clinical situation will allow, with a minimum of 14 days. initial dosage should be low and increases should be gradual and cautiously prescribed. the drug is contraindicated during the acute recovery period after a myocardial infarction. patients with a known hypersensitivity to this compound should not be given the drug. the possibility of cross-sensitivity to other dibenzazepine compounds should be kept in mind.

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - imipramine hydrochloride (unii: bke5q1j60u) (imipramine - unii:ogg85sx4e4) - imipramine hydrochloride 25 mg - for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than other depressive states. one to three weeks of treatment may be needed before optimal therapeutic effects are evident. may be useful as temporary adjunctive therapy in reducing enuresis in children aged 6 years and older, after possible organic causes have been excluded by appropriate tests. in patients having daytime symptoms of frequency and urgency, examination should include voiding cystourethrography and cystoscopy, as necessary. the effectiveness of treatment may decrease with continued drug administration. the concomitant use of monoamine oxidase inhibiting compounds is contraindicated. hyperpyretic crises or severe convulsive seizures may occur in patients receiving such combinations. the potentiation of adverse effects can be serious, or even fatal. when it is desired to substitute imipramine hydrochloride tablets in patients receiving a monoamine oxidase inhibitor, as long an interval should elapse a

Israel - English - Ministry of Health

novartis israel ltd - methylphenidate hydrochloride - modified release capsules - methylphenidate hydrochloride 10 mg - methylphenidate - attention deficit hyperactivity disorder (adhd) .

Israel - English - Ministry of Health

novartis israel ltd - methylphenidate hydrochloride - modified release capsules - methylphenidate hydrochloride 20 mg - methylphenidate - attention deficit hyperactivity disorder (adhd).